AGP Picks
View all

Texas Technology Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Texas Technology Digest.

Press releases published on October 12, 2026

Businesses Turn to Google Maps Data to Improve Lead Generation
Mente Upgrades Aircraft Values Platform with Transaction Data and Long-Term Projections
Principled Technologies releases study showing Dell PowerEdge R4715 offers strong SQL Server performance for SMBs
Dell PowerEdge XE9780LAP with Intel Xeon 6 supports up to 205 AI agents in PT agentic AI tests
Innovorbs Technologies Launches Affordable VMware Managed Services for vSphere, NSX, VCF, and Avi Load Balancer
Proximity Learning Wins Tech & Learning Award of Excellence for Secondary Education
Mobisoft Infotech Expands AI-Native Product Engineering for Enterprise Innovation
NexLife Announces October 2026 GLP-1 Price Index on Online Prices of Compounded Tirzepatide and Semaglutide
Teva to Host R&D Day on Wednesday, November 11 in New York City
Biomea Fusion to Announce Phase I Results for BMF-650, Its Next-Generation Oral Small-Molecule GLP-1 Receptor Agonist
Bitdeer AI Expands Malaysia Campus with New 60MW A103 Facility, Closing in on Up-to-350MW Global Capacity Target
Organogenesis Announces Publication of Peer-Reviewed PREPARE Trial Results Demonstrating Clinical Benefit of PuraPly®AM for Hard-to-Heal Diabetic Foot Ulcers
BridgeBio Oncology Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2026 Financial Results on November 5, 2026
Apnimed to Present Five Abstracts, Including Two Late-Breakers at CHEST 2026
PROCEPT BioRobotics® to Report Third Quarter 2026 Financial Results on November 4th, 2026
Nurix Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update
ImmuCell Announces a 46% Increase in Product Sales in Quarter Three of 2026, Based on Preliminary, Unaudited Sales Results
Oncolytics Biotech® Secures Patent Protection to Late 2040s and Provides Intellectual Property Portfolio Update
ArriVent Announces First Patient Dosed with Novel Tetravalent MUC16/NaPi2b Dual Target ADC, ARR-002

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Texas Technology Digest

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.